Prevalence of Comorbidities in Patients Undergoing Oncosurgeries at Tertiary Cancer Institute in North India.

NCT05038501 | Completed

• 1 other identifier: RGCI \ MK 1967
• Study Type: observational
• Target: 150
• Locations: 1 country
• Sites: 1

Brief Summary

Investigators plan to study the prevalence of comorbidities in patients undergoing oncosurgeries

Conditions

Comorbidities and Coexisting Conditions

Keywords

comorbidities; oncosurgery

Outcome Measures

Primary Outcomes (2)

• To study Coronary Artery disease in patients undergoing Oncosurgeries

  Electrocardiography and Echocardiography will be performed. Investigators will measure Blood Pressure , Blood Sugar , Thyroid Function Test and previous Corona Virus Infection

  60 days

• To study Diabetes Mellitus in patients undergoing Oncosurgeries.

  Random Blood Sugar in milligram/Decilitre will be measured.

  60days

Secondary Outcomes (1)

• To study Hypothyroidism in patients undergoing Oncosurgeries

  60 days

Study Arms (1)

Comorbidities in Oncosurgery patients

Prevalence of comorbidities as Coronary artery disease, Hypertension , Diabetes Mellitus,Hypothyroidism and Corona Virus Infection will be studied in patients undergoing Oncosurgeries.

Other: To study comorbidities in patients undergoing Oncosurgeries

Interventions

To study comorbidities in patients undergoing Oncosurgeries OTHER

In the Preoperative Anaesthesia checkup we will study prevalence of comorbidities as Coronary artery Disease, Hypertension, Diabetes Mellitus , Hypothyroidism and prior Corona Virus Infection in patients undergoing Oncosurgeries

Comorbidities in Oncosurgery patients

Eligibility Criteria

• Age: 35 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patients undergoing Oncosurgeries will be studied for prevalence of comorbidites.

You may not qualify if:

• Age below 40 years Emergency Surgery Patient Refusal

Sponsors & Collaborators

• Rajiv Gandhi Cancer Institute & Research Center, India: lead

Study Sites (1)

Anita Kulkarni

Delhi, 110085, India

Location

Related Publications (2)

• Gupta R, Mohan I, Narula J. Trends in Coronary Heart Disease Epidemiology in India. Ann Glob Health. 2016 Mar-Apr;82(2):307-15. doi: 10.1016/j.aogh.2016.04.002.

  PMID: 27372534 BACKGROUND

• Ranasinghe P, Jayawardena R, Gamage N, Sivanandam N, Misra A. Prevalence and trends of the diabetes epidemic in urban and rural India: A pooled systematic review and meta-analysis of 1.7 million adults. Ann Epidemiol. 2021 Jun;58:128-148. doi: 10.1016/j.annepidem.2021.02.016. Epub 2021 Mar 13.

  PMID: 33727086 BACKGROUND

Study Officials

• Anita Kulkarni, MD

  Rajiv Gandhi Cancer Institute and RC , Delhi, INDIA

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Senior Consultant

Study Record Dates

• First Submitted: August 15, 2021
• First Posted: September 9, 2021
• Study Start: July 1, 2021
• Primary Completion: August 31, 2021
• Study Completion: August 31, 2021
• Last Updated: October 4, 2021

Record last verified: 2021-10

Data Sharing

• IPD Sharing: Will not share

Locations

IN (1)